These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 922795)

  • 1. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract]   [Full Text] [Related]  

  • 2. Iodine-123-iododeoxyuridine: a potential indicator of tumour response to treatment.
    Robins AB; Taylor DM
    Int J Nucl Med Biol; 1981; 8(1):53-63. PubMed ID: 7228519
    [No Abstract]   [Full Text] [Related]  

  • 3. Localized incorporation of iododeoxyuridine from polycation-complexed iododeoxycytidylic acid into DNA of several murine and hamster tumors.
    Woodman RJ
    Cancer Res; 1968 Oct; 28(10):2007-16. PubMed ID: 5696932
    [No Abstract]   [Full Text] [Related]  

  • 4. Reutilization of 125I-UdR during growth of a solid mammary carcinoma: implications for the 125I-UdR loss technique.
    Porschen R; Porschen W; Mühlensiepen H; Feinendegen LE
    Strahlenther Onkol; 1987 Nov; 163(11):723-8. PubMed ID: 3686335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell loss from three established lines of the C3H mouse mammary tumor: a comparison of the 125I-UdR and the 3H-TdR-autoradiographic methods.
    Dethlefsen LA; Sorenson J; Snively J
    Cell Tissue Kinet; 1977 Sep; 10(5):447-59. PubMed ID: 922798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell kinetics methods for clinical use: assessment of autoradiography and 125I-iodo-deoxyuridine with mouse Ehrlich tumour.
    Jenkinson IS; Shuter BJ; Wright PN
    Cell Tissue Kinet; 1975 Jul; 8(4):307-20. PubMed ID: 1149073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double labeling with [3H]thymidine and [125I]iododeoxyuridine as a method for determining the fate of injected DNA and cells in vivo.
    Myers DK; Feinendegen LE
    J Cell Biol; 1975 Nov; 67(2PT.1):484-8. PubMed ID: 1194358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Isolation, analysis and radioactive labeling of nucleic acids from rat tumors induced by polyoma virus].
    Pokorný J; Fasske E; Fetting R; Reth S
    Z Krebsforsch; 1970; 74(3):219-26. PubMed ID: 4325440
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thymidine incorporation and 02 concentration in explants of normal and malignant tissues "in vitro"].
    Rajewski MF
    Naturwissenschaften; 1965 Jun; 52(12):341-2. PubMed ID: 5324555
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model.
    Bloomer WD; Adelstein SJ
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):513-25. PubMed ID: 639561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of tritiated thymidine in P388F lymphoma cells. I. Incorporation into DNA and cell survival.
    Peterson AR; Fox BW; Fox M
    Int J Radiat Biol Relat Stud Phys Chem Med; 1971; 19(2):123-32. PubMed ID: 5313805
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell population growth and cell loss in the MTG-B mouse mammary carcinoma.
    Clifton KH; Yatvin MB
    Cancer Res; 1970 Mar; 30(3):658-64. PubMed ID: 5425291
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytocidal effect of rifamycin derivatives on ascites tumor cells: studies with [125I]iododeoxyuridine.
    Hughes AM; Calvin M
    Cancer Lett; 1979 Jan; 6(1):15-9. PubMed ID: 544007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotoxicity of intranuclear tritium, 125 iodine and 131 iodine.
    Hofer KG; Hughes WL
    Radiat Res; 1971 Jul; 47(1):94-101. PubMed ID: 5559387
    [No Abstract]   [Full Text] [Related]  

  • 16. Incorporation of iododeoxyuridine into neoplastic DNA: a fraudulent magic bullet?
    Calabresi P; Curt G
    Hepatology; 1990 Jan; 11(1):145-6. PubMed ID: 2295464
    [No Abstract]   [Full Text] [Related]  

  • 17. Incorporation of thymidine and iododeoxyuridine into the DNA of mouse tissues.
    Myers DK; Feinendegen LE
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1014-22. PubMed ID: 1222371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets.
    Lee DJ; Prensky W; Krause G; Hughes WL
    Cancer Res; 1976 Dec; 36(12):4577-83. PubMed ID: 1000502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]thymidine labels less than half of the DNA-synthesizing cells in the mouse tumour, carcinoma NT.
    Hamilton E; Dobbin J
    Cell Tissue Kinet; 1982 Jul; 15(4):405-11. PubMed ID: 7105131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immunostimulation. I. Increased uptake of (125I)iododeoxyuridine and (3H)thymidine into TNP-cells treated with anti-TNP antibody.
    Shearer WT; Philpott GW; Parker CW
    J Exp Med; 1974 Feb; 139(2):367-79. PubMed ID: 4855754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.